Company reports continued clinical adoption, expanding reimbursement coverage, and established commercial manufacturing capacity CUMBERLAND, R.I., March 12, 2026--(BUSINESS WIRE)--Neurotech ...

Please provide your email address to receive an email when new articles are posted on . “The entire Neurotech family mourns this loss,” the company said in a statement. “On behalf of the board of ...

Neurotech Pharmaceuticals, Inc., a clinical stage biotech company, today announced the expansion of its executive team with the appointment of Scott Hunter as Chief Commercial Officer bringing two ...

Neurotech Pharmaceuticals, Inc. (the "Company") today provided an update on its ongoing transition to a commercial--stage company following the first anniversary of the FDA's approval of ENCELTO(TM) ...